Abstract
(JAMA. 2019;322:145–152) The rate of cannabis use among pregnant women in Canada was 2% in 2017. With recent legalization, it is anticipated that cannabis use among pregnant women will continue to rise. Cannabinoids can cross the placenta and enter the fetal blood supply. Previous studies have demonstrated a relationship between pregnant mothers who use cannabinoids and increased incidence of low birth weight, small for gestational age (SGA), stillbirth, and admission to neonatal intensive care. The aim of this study was to evaluate associations between reported prenatal cannabis use and maternal, perinatal, and neonatal outcomes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
